Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa.

Source:http://linkedlifedata.com/resource/pubmed/id/17509133

Download in:

View as

General Info

PMID
17509133